ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.014,18
-0,10%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ALX Oncology Holdings Inc (ALXO)

  7. ALX Oncology Holdings Inc (ALXO) Notícias

ALXO

ALX Oncology (ALXO)

ALX Oncology Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALXO
DataHoraFonteTítuloCódigoCompanhia
15/05/202417:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALXOALX Oncology Holdings Inc
13/05/202417:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALXOALX Oncology Holdings Inc
09/05/202417:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALXOALX Oncology Holdings Inc
09/05/202417:00GlobeNewswire Inc.ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ALXOALX Oncology Holdings Inc
07/05/202410:00GlobeNewswire Inc.ALX Oncology Appoints Allison Dillon as Chief Business OfficerNASDAQ:ALXOALX Oncology Holdings Inc
30/04/202410:00GlobeNewswire Inc.ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal CancerNASDAQ:ALXOALX Oncology Holdings Inc
24/04/202411:00GlobeNewswire Inc.ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual MeetingNASDAQ:ALXOALX Oncology Holdings Inc
09/04/202418:30GlobeNewswire Inc.ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)NASDAQ:ALXOALX Oncology Holdings Inc
07/03/202418:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALXOALX Oncology Holdings Inc
07/03/202418:03GlobeNewswire Inc.ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ALXOALX Oncology Holdings Inc
05/03/202418:30GlobeNewswire Inc.ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual MeetingNASDAQ:ALXOALX Oncology Holdings Inc
03/01/202410:00GlobeNewswire Inc.ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ALXOALX Oncology Holdings Inc
13/11/202318:05GlobeNewswire Inc.ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ALXOALX Oncology Holdings Inc
01/11/202317:05GlobeNewswire Inc.ALX Oncology Announces November Investor Conference ParticipationNASDAQ:ALXOALX Oncology Holdings Inc
10/10/202317:05GlobeNewswire Inc.ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:ALXOALX Oncology Holdings Inc
06/10/202307:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALXOALX Oncology Holdings Inc
05/10/202309:00GlobeNewswire Inc.ALX Oncology Announces Pricing of Public OfferingNASDAQ:ALXOALX Oncology Holdings Inc
04/10/202317:10GlobeNewswire Inc.ALX Oncology Announces Proposed Public OfferingNASDAQ:ALXOALX Oncology Holdings Inc
03/10/202311:03IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNASDAQ:ALXOALX Oncology Holdings Inc
03/10/202307:00GlobeNewswire Inc.ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric CancerNASDAQ:ALXOALX Oncology Holdings Inc
02/10/202317:05GlobeNewswire Inc.ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric CancerNASDAQ:ALXOALX Oncology Holdings Inc
20/09/202309:45InvestorsHub NewsWirePathways to Progress: How Orphan Drug Designation Sparks Biotech TransformationNASDAQ:ALXOALX Oncology Holdings Inc
11/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ALXOALX Oncology Holdings Inc
08/09/202317:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ALXOALX Oncology Holdings Inc
06/09/202309:00GlobeNewswire Inc.ALX Oncology Realigns Executive Leadership TeamNASDAQ:ALXOALX Oncology Holdings Inc
01/09/202317:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ALXOALX Oncology Holdings Inc
31/08/202308:00GlobeNewswire Inc.ALX Oncology Announces September Investor Conference ParticipationNASDAQ:ALXOALX Oncology Holdings Inc
10/08/202317:01GlobeNewswire Inc.ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program UpdateNASDAQ:ALXOALX Oncology Holdings Inc
26/06/202308:00GlobeNewswire Inc.ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric CancerNASDAQ:ALXOALX Oncology Holdings Inc
22/06/202317:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXOALX Oncology Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALXO

Seu Histórico Recente

BIT
UC8XWH
Unicredit Bank
BIT
UB0P2G
UniCredit Bank
COIN
JAMMUSD
Tune.FM
NASDAQ
CSTE
Caesarstone
LSE
73RU
Hsbc Hldg.25
COIN
LDMBTC
COIN
SAPPPUSD
USOTC
FCTXZ
Farm Credit Bank of Texas (CE)
NASDAQ
PTCRX
Performance Trust Credit...
LSE
0HBS
Ubs Etf-msci Japan Hgd T...
COIN
BCBBUSD
Blockchain Bets
COIN
XNOOBTC
BIT
P12V70
BNP PARIBAS ISSUANCE
USOTC
GENGF
Gear Energy (QX)
COIN
GTXXUST
Global Trading Xenocurrency
LSE
ZT83
Citi Fun 33
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados